| Banff 2013 meeting report: inclusion of c4d‐negative antibody‐mediated rejection and antibody‐associated arterial lesions M Haas, B Sis, LC Racusen, K Solez, D Glotz, RB Colvin, MCR Castro, ... American journal of transplantation 14 (2), 272-283, 2014 | 1398 | 2014 |
| The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for integrative … M Haas, A Loupy, C Lefaucheur, C Roufosse, D Glotz, D Seron, ... American Journal of Transplantation 18 (2), 293-307, 2018 | 1054 | 2018 |
| Complement-binding anti-HLA antibodies and kidney-allograft survival A Loupy, C Lefaucheur, D Vernerey, C Prugger, JPD van Huyen, ... New England Journal of Medicine 369 (13), 1215-1226, 2013 | 932 | 2013 |
| Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation C Lefaucheur, A Loupy, GS Hill, J Andrade, D Nochy, C Antoine, ... Journal of the American Society of Nephrology 21 (8), 1398-1406, 2010 | 910 | 2010 |
| Rituximab and intravenous immune globulin for desensitization during renal transplantation AA Vo, M Lukovsky, M Toyoda, J Wang, NL Reinsmoen, CH Lai, A Peng, ... New England Journal of Medicine 359 (3), 242-251, 2008 | 790 | 2008 |
| The Banff 2015 kidney meeting report: current challenges in rejection classification and prospects for adopting molecular pathology A Loupy, M Haas, K Solez, L Racusen, D Glotz, D Seron, BJ Nankivell, ... American journal of transplantation 17 (1), 28-41, 2017 | 719 | 2017 |
| A 2018 reference guide to the Banff classification of renal allograft pathology C Roufosse, N Simmonds, M Clahsen-van Groningen, M Haas, ... Transplantation 102 (11), 1795-1814, 2018 | 666 | 2018 |
| The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell–and antibody‐mediated rejection A Loupy, M Haas, C Roufosse, M Naesens, B Adam, M Afrouzian, ... American Journal of Transplantation 20 (9), 2318-2331, 2020 | 574 | 2020 |
| Banff 2011 Meeting report: new concepts in antibody-mediated rejection M Mengel, B Sis, M Haas, RB Colvin, PF Halloran, LC Racusen, K Solez, ... American Journal of Transplantation 12 (3), 563-570, 2012 | 515 | 2012 |
| The impact of donor-specific anti-HLA antibodies on late kidney allograft failure A Loupy, GS Hill, SC Jordan Nature Reviews Nephrology 8 (6), 348-357, 2012 | 438 | 2012 |
| Antibody-mediated rejection of solid-organ allografts A Loupy, C Lefaucheur New England Journal of Medicine 379 (12), 1150-1160, 2018 | 408 | 2018 |
| Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies A Loupy, C Suberbielle-Boissel, GS Hill, C Lefaucheur, D Anglicheau, ... American Journal of Transplantation 9 (11), 2561-2570, 2009 | 404 | 2009 |
| Antibody-mediated vascular rejection of kidney allografts: a population-based study C Lefaucheur, A Loupy, D Vernerey, JP Duong-Van-Huyen, C Suberbielle, ... The Lancet 381 (9863), 313-319, 2013 | 388 | 2013 |
| Assessment of tocilizumab (anti–interleukin-6 receptor monoclonal) as a potential treatment for chronic antibody-mediated rejection and transplant glomerulopathy in HLA … J Choi, O Aubert, A Vo, A Loupy, M Haas, D Puliyanda, I Kim, S Louie, ... American Journal of Transplantation 17 (9), 2381-2389, 2017 | 321 | 2017 |
| Organ procurement and transplantation during the COVID-19 pandemic A Loupy, O Aubert, PP Reese, O Bastien, F Bayer, C Jacquelinet The Lancet 395 (10237), e95-e96, 2020 | 316 | 2020 |
| Molecular diagnosis of antibody‐mediated rejection in human kidney transplants J Sellarés, J Reeve, A Loupy, M Mengel, B Sis, A Skene, DG De Freitas, ... American Journal of Transplantation 13 (4), 971-983, 2013 | 314 | 2013 |
| IgG donor-specific anti-human HLA antibody subclasses and kidney allograft antibody-mediated injury C Lefaucheur, D Viglietti, C Bentlejewski, JPD van Huyen, D Vernerey, ... Journal of the American Society of Nephrology 27 (1), 293-304, 2016 | 312 | 2016 |
| Subclinical rejection phenotypes at 1 year post-transplant and outcome of kidney allografts A Loupy, D Vernerey, C Tinel, O Aubert, JPD van Huyen, M Rabant, ... Journal of the American Society of Nephrology 26 (7), 1721-1731, 2015 | 309 | 2015 |
| Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor‐specific antibodies (DSA) A Loupy, GS Hill, C Suberbielle, D Charron, D Anglicheau, J Zuber, ... American Journal of Transplantation 11 (1), 56-65, 2011 | 279 | 2011 |
| Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study A Loupy, O Aubert, BJ Orandi, M Naesens, Y Bouatou, M Raynaud, ... Bmj 366, 2019 | 253 | 2019 |
Jean-Paul Duong Van Huyen在 nck.aphp.fr 的电子邮件经过验证
